Full text is available at the source.
Abstract
This cohort study investigates the association between weight loss after bariatric surgery and preoperative use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs).
- Weight loss following bariatric surgery may be influenced by the use of GLP-1 RAs before the procedure.
- The study examines how preoperative medication impacts postoperative outcomes.
- Findings could provide insights into optimizing weight loss strategies for bariatric surgery patients.
Simplified
GLP-1 Therapies